Compliance, Marijuana, Medical Evaluation and Recreational

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Compliance

Marijuana

Medical Evaluation

Recreational

Document: Barr Responses To QFR’s: CLR Digs Out The Relevant Q’s & A’s

Cannabis Law Report

JANUARY 30, 2019

To expand the number of manufacturers, the Drug Enforcement Administration (DEA) submitted a notice in the Federal Register on August 11, 2016, soliciting applications for licenses to manufacture marijuana for research purposes. However, over two years have passed without any new schedule I marijuana manufacturer registrations.

Research and Development

Research and Development DEA CBD Law

Further Consideration of the STATES Act

Cannabis Law Report

MARCH 25, 2019

Ron Paul (R-TX) and Barney Frank (D-MA) introduced a bill to remove marijuana from the schedules entirely (“de-scheduling”). The Attorney General forwards the request to the Health and Human Services Secretary and requests a scientific and medical evaluation and recommendation, as specified by 23 USC 811(b-c). In 2011, Reps.

Banking

Banking Law Marijuana State Laws

Medical Cannabis Brief

Document: Barr Responses To QFR’s: CLR Digs Out The Relevant Q’s & A’s

Further Consideration of the STATES Act

Stay Connected